Integrated Filing — IndAS


General information about company

Scrip Code 540900
NSE Symbol NEWGEN
MSEI Symbol NOTLISTED
ISIN INE619B01017
Name of company NEWGEN SOFTWARE TECHNOLOGIES LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 02-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 24-Apr-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Geographical
Description of single segment
Start date and time of board meeting 02-May-2025   11:19:00
End date and time of board meeting 02-May-2025   12:10:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion



Financial Results Ind-AS

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 4298898000 14868792000
Other income 141183000 635759000
Total income 4440081000 15504551000
2 Expenses
(a) Cost of materials consumed 0 0
(b) Purchases of stock-in-trade 0 0
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 0 0
(d) Employee benefit expense 1940852000 7410438000
(e) Finance costs 14127000 47720000
(f) Depreciation, depletion and amortisation expense 86453000 330413000
(f) Other Expenses
1 Other expenses 985937000 3696301000
Total other expenses 985937000 3696301000
Total expenses 3027369000 11484872000
3 Total profit before exceptional items and tax 1412712000 4019679000
4 Exceptional items 0 0
5 Total profit before tax 1412712000 4019679000
6 Tax expense
7 Current tax 332331000 987201000
8 Deferred tax -3011000 -119946000
9 Total tax expenses 329320000 867255000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 1083392000 3152424000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 1083392000 3152424000
17 Other comprehensive income net of taxes 19276000 35449000
18 Total Comprehensive Income for the period 1102668000 3187873000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 1083392000 3152424000
Total profit or loss, attributable to non-controlling interests 0 0
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 19276000 35449000
Total comprehensive income for the period attributable to owners of parent non-controlling interests 0 0
21 Details of equity share capital
Paid-up equity share capital 1402130000 1402130000
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve 13762192000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 7.73 22.53
Diluted earnings (loss) per share from continuing operations 7.58 21.89
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 7.73 22.53
Diluted earnings (loss) per share from continuing and discontinued operations 7.58 21.89
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Notes:tttttt n1. The above financial results for the quarter and year ended 31 March 2025 were reviewed by the Audit Committee in their meeting held on 1 May 2025 and approved by the Board of Directors in their meeting held on 2 May 2025. Standalone and Consolidated financial results of the Company for the quarter and year ended 31 March 2025 are prepared in accordance with Indian Accounting Standards (Ind AS) prescribed under Section 133 of the Companies Act, 2013 and relevant rules thereunder. The company has complied with the guidelines issued by Securities & Exchange Board of India (SEBI) to the extent applicable.ttttt n2. The auditors have carried out audit of Standalone and Consolidated results of the Company for the year ended 31 March 2025. There are no qualifications in the Auditor's report on these financial results. The figures for the quarter ended 31 March 2025 and 31 March 2024 are the balancing figures between the audited figures for full financial year and the unaudited figures upto the nine months ended 31 December 2024 and 31 December 2023, respectively, which were subjected to limited review by the statutory auditors. ttttt n3 The Board of Directors in their meeting held on 2 May 2025 recommended a dividend of INR 5.00 per equity share for the financial year ended 31 March 2025. The payment is subject to approval of shareholders at the ensuing Annual General Meeting.ttttt n4 Pursuant to Newgen ESOP Scheme 2022 and Newgen RSU 2021 scheme, the Board of Directors on 20 January 2025, allotted 3,93,385 and 9,40,000 shares respectively to Newgen ESOP Trust and Newgen RSU Trust through primary issue. Further, during the quarter, the Nomination & Remuneration Committee has granted 73,050 options to its employees under Newgen ESOP Scheme 2022 on 20 January 2025.ttttt n5tPrevious periods/years figures have been regrouped/reclassified wherever necessary to correspond with the current period/year classification/disclosure, which are not considered material to these financial results.tt nFor and on behalf of the Board of Directors of nNewgen Software Technologies Limited n nDiwakar Nigam nChairman & Managing Director nDIN: 00263222 n nPlace: New Delhi nDate: 2 May 2025



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 1721645000
Capital work-in-progress 0
Investment property 0
Goodwill 28331000
Other intangible assets 839077000
Intangible assets under development 0
Biological assets other than bearer plants 0
Investments accounted for using equity method 0
Non-current financial assets
Non-current investments 0
Trade receivables, non-current 0
Loans, non-current 0
Other non-current financial assets 949012000
Total non-current financial assets 949012000
Deferred tax assets (net) 213478000
Other non-current assets 4761000
Total non-current assets 3756304000
2 Current assets
Inventories 0
Current financial asset
Current investments 5083962000
Trade receivables, current 5566798000
Cash and cash equivalents 1037700000
Bank balance other than cash and cash equivalents 3117310000
Loans, current 5311000
Other current financial assets 196924000
Total current financial assets 15008005000
Current tax assets (net) 215648000
Other current assets 1470826000
Total current assets 16694479000
3 Non-current assets classified as held for sale 0
4 Regulatory deferral account debit balances and related deferred tax Assets 0
Total assets 20450783000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 1402130000
Other equity 13762191000
Total equity attributable to owners of parent 15164321000
Non controlling interest
Total equity 15164321000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0
Total Trade payable 0
Other non-current financial liabilities 408121000
Total non-current financial liabilities 408121000
Provisions, non-current 555279000
Deferred tax liabilities (net) 0
Deferred government grants, Non-current 0
Other non-current liabilities 0
Total non-current liabilities 963400000
Current liabilities
Current financial liabilities
Borrowings, current 0
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 27792000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 476926000
Total Trade payable 504718000
Other current financial liabilities 739905000
Total current financial liabilities 1244623000
Other current liabilities 2678301000
Provisions, current 96271000
Current tax liabilities (Net) 303867000
Deferred government grants, Current 0
Total current liabilities 4323062000
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 5286462000
Total equity and liabilites 20450783000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 India 1336367000 4586841000
2 EMEA 1385670000 4812459000
3 APAC 692165000 2304905000
4 USA 884696000 3164587000
Total Segment Revenue 4298898000 14868792000
Less: Inter segment revenue
Revenue from operations 4298898000 14868792000
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 India 273438000 722087000
2 EMEA 516259000 1510811000
3 APAC 266830000 799080000
4 USA 320583000 751479000
Total Profit before tax 1377110000 3783457000
i. Finance cost 14127000 14127000
ii. Other Unallocable Expenditure net off Unallocable income -49729000 -49729000
Profit before tax 1412712000 4019679000
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 India 2570124000 2570124000
2 EMEA 2908782000 2908782000
3 APAC 1274822000 1274822000
4 USA 2193307000 2193307000
Total Segment Asset 8947035000 8947035000
Un-allocable Assets 11503748000 11503748000
Net Segment Asset 20450783000 20450783000
4 Segment Liabilities
Segment Liabilities
1 India 1176848000 1176848000
2 EMEA 1288167000 1288167000
3 APAC 646113000 646113000
4 USA 1046894000 1046894000
Total Segment Liabilities 4158022000 4158022000
Un-allocable Liabilities 1128440000 1128440000
Net Segment Liabilities 5286462000 5286462000
Disclosure of notes on segments Textual Information(2)



Text Block

Textual Information(2) a) Unallocated assets, liabilities, revenue and expenses : nCertain assets, liabilities, revenue and expenses are not specifically allocable to individual segments as the underlying services are used interchangeably. The Company nbelieves that it is not practicable to provide segment disclosures relating to such assets, liabilities, revenue and expenses and accordingly such assets, liabilities, nrevenue and expenses are separately disclosed as ‘unallocated’.



Other Comprehensive Income

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Re-measurement gains / (losses) on defined benefit plans 19349000 -10952000
Total Amount of items that will not be reclassified to profit and loss 19349000 -10952000
2 Income tax relating to items that will not be reclassified to profit or loss 6761000 -3827000
3 Amount of items that will be reclassified to profit and loss
1 Debt instruments through other comprehensive income - netnchange in fair value -3975000 -15135000
2 Exchange differences on translation of foreign operations 9737000 54183000
Total Amount of items that will be reclassified to profit and loss 5762000 39048000
4 Income tax relating to items that will be reclassified to profit or loss -926000 -3526000
5 Total Other comprehensive income 19276000 35449000



Cash flow statement, indirect

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 2024-04-01
B Date of end of reporting period 2025-03-31
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Consolidated
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 4019679000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 46665000
Adjustments for decrease (increase) in inventories 0
Adjustments for decrease (increase) in trade receivables, current -1436736000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets -506470000
Adjustments for decrease (increase) in other non-current assets -2975000
Adjustments for other financial assets, non-current -37633000
Adjustments for other financial assets, current -38491000
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current 62449000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 259969000
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 330414000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current 5455000
Adjustments for provisions, non-current 59276000
Adjustments for other financial liabilities, current 86612000
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains 18188000
Adjustments for dividend income 0
Adjustments for interest income 278135000
Adjustments for share-based payments 253942000
Adjustments for fair value losses (gains) -198329000
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow -92719000
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 306429000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) -1162089000
Net cash flows from (used in) operations 2857590000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 707823000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities 2149767000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 2958156000
Other cash payments to acquire equity or debt instruments of other entities 4117658000
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 2617000
Purchase of property, plant and equipment 233499000
Proceeds from sales of investment property 0
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 328623000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -659429000
Net cash flows from (used in) investing activities -1721190000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 48523000
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 0
Repayments of borrowings 21992000
Payments of lease liabilities 145105000
Dividends paid 560857000
Interest paid 1432000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities -680863000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes -252286000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 44255000
Net increase (decrease) in cash and cash equivalents -208031000
Cash and cash equivalents cash flow statement at beginning of period 1245731000
Cash and cash equivalents cash flow statement at end of period 1037700000







Details of Impact of Audit Qualification

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Walker Chandiok & Co LLP Yes 31-May-2025


Financial details

Sr. Particulars Audited Figures (as reported before adjusting for qualifications) Adjusted Figures (audited figures after adjusting for qualifications)
1 Turnover / Total income
2 Total Expenditure
3 Net Profit/(Loss)
4 Earnings Per Share
5 Total Assets
6 Total Liabilities
7 Net Worth




Signatories detail

Name of CEO / Managing director
Name of CFO
Name of audit committee chairman
Name of statutory auditor
Name of other signatory, if any, with designation
Place
Date